The former CEO of a Texas hospital has agreed to pay more than $5.3 million to resolve allegations under the False Claims Act involving laboratory testing.
Legal & Regulatory Issues
California attorney general Rob Bonta filed a lawsuit against AHMC Healthcare on Oct. 2, claiming the Alhambra-based health system's service reductions at one Bay Area hospital and closure of another facility violate conditions set by the state when it acquired…
The Department of Justice has filed a statement of interest siding with UPMC workers in an ongoing antitrust lawsuit alleging the Pittsburgh-based health system prevented workers from exiting or improving their working conditions, suppressed their wages and benefits, and increased…
The owner of a Chicago laboratory pleaded guilty to his role in a $14 million COVID-19 testing fraud scheme.
The Consumer Financial Protection Bureau issued an advisory opinion on Oct. 1 warning debt collectors — including third-party revenue cycle management companies — that they are violating federal law when they collect on inaccurate or invalid medical debts.
A $400 million fraud and kickback case against former Tenet Healthcare executives may finally advance to trial after federal investigators received the green light to use statements from 10 alleged co-conspirators, The Atlanta Journal-Constitution reported Sept. 30.
A hospital, a laboratory, three lab employees, a referring physician and his office manager agreed to collectively pay more than $7.2 million to resolve allegations they defrauded healthcare programs through unnecessary or tainted laboratory testing.
Gov. Gavin Newsom signed Senate Bill 1300 into law Sept. 28, which requires hospitals to notify the state when planning to close labor and delivery or psychiatric units, according to a Sept. 29 CalMatters report.
The owner of three Ohio-based home healthcare companies was convicted on all 13 charges against her in a Medicaid fraud scheme.
The former CFO and president of a New Jersey-based pharmacy pleaded guilty to their roles in a $33 million compounded medication kickback scheme.